what tirzepatide is approved for weight loss Dosage The Science Behind Tirzepatide Medical

Tirzepatide, a dual GIP and GLP-1 receptor agonist licensed for type 2 diabetes, and phentermine, an unlicensed sympathomimetic appetite suppressant, work through entirely different mechanisms

Your injection will be ready when you arrive

Ozempic and Stomach Paralysis (Gastroparesis) Research suggests that Ozempic and other GLP-1 receptor agonists may substantially increase a persons risk of developing gastroparesis or stomach paralysis

Sci Rep 14(1):15968

Foods to avoid during treatment remain important after treatment

Schedule a free consultation today to learn more and see if this treatment is a good match for your goals